ESC 365 - Effect of evolocumab on lipoprotein(a) levels: results across 15 studies

ESC Premium Access

Effect of evolocumab on lipoprotein(a) levels: results across 15 studies

Session: Poster Session 6 - Lipids

Topic: Drug therapy

Speaker: Professor P. Toth (Baltimore, US)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Peter Toth

CGH Medical Center and The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore (United States of America)

5 presentations

0 follower

13 more presentations in this session

Reduction in high-sensitivity C-reactive protein by pitavastatin was associated with improved outcomes in Japanese patients with stable coronary artery disease: results from REAL-CAD study

Speaker: Doctor H. Iwata (Tokyo, JP)

The association of Lp(a) levels and cardiovascular disease in adult patients with familial hypercholesterolemia: analysis from the HELLAS-FH registry

Speaker: Professor E. Liberopoulos (Athens, GR)

Oxidized phospholipids on apolipoprotein B-100 among black US adults with and without PCSK9 loss-of-function variants

Speaker: Doctor M. Mefford (Birmingham, US)

HDL-C and all-cause mortality in a high-risk population: impact of LDL-C

Speaker: Doctor D. Dhindsa (Atlanta, US)

Children with familial hypercholesterolemia: lipid profile, treatment and evaluation of different formulas for calculating low-density lipoprotein cholesterol: an analysis from the HELLAS-FH registry

Speaker: Professor E. Liberopoulos (Athens, GR)

Access the full session

Poster Session 6 - Lipids

Speakers: Professor P. Toth, Doctor H. Iwata, Professor E. Liberopoulos, Doctor M. Mefford, Doctor D. Dhindsa...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources